These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 28891405)

  • 1. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
    Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
    Suh S; Kim YH; Goh TS; Lee J; Jeong DC; Oh SO; Hong JC; Kim SJ; Kim IJ; Pak K
    Endocrine; 2017 Dec; 58(3):495-502. PubMed ID: 29030773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
    Chen Z; Ruan J; Yao Y; Wen L; Mao Z; Chen S; Zhu H; Zhao Y; Li Z; Fahey TJ; Teng L; Wang W
    Ann Surg Oncol; 2021 Oct; 28(11):6564-6571. PubMed ID: 33521903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
    Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
    J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.
    Kitpanit S; Jittapiromsak N; Sriyook A; Prayongrat A; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
    Jpn J Clin Oncol; 2019 Dec; 49(12):1100-1113. PubMed ID: 31334768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
    Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
    Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.
    Kim M; Kim WG; Oh HS; Park S; Kwon H; Song DE; Kim TY; Shong YK; Kim WB; Sung TY; Jeon MJ
    Thyroid; 2017 Sep; 27(9):1149-1155. PubMed ID: 28635571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
    Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1095-e1106. PubMed ID: 28843376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
    Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
    Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
    Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
    Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.